Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Steven A. Lubitz, M.D.

Co-Author

This page shows the publications co-authored by Steven Lubitz and Patrick Ellinor.
Connection Strength

20.295
  1. Somatic mutations and atrial fibrillation: the end or just the beginning? Circ Cardiovasc Genet. 2015 Feb; 8(1):2-3.
    View in: PubMed
    Score: 0.624
  2. Next-generation sequencing for the diagnosis of cardiac arrhythmia syndromes. Heart Rhythm. 2015 May; 12(5):1062-70.
    View in: PubMed
    Score: 0.623
  3. Novel genetic markers associate with atrial fibrillation risk in Europeans and Japanese. J Am Coll Cardiol. 2014 Apr 01; 63(12):1200-1210.
    View in: PubMed
    Score: 0.582
  4. Personalized medicine and atrial fibrillation: will it ever happen? BMC Med. 2012 Dec 04; 10:155.
    View in: PubMed
    Score: 0.537
  5. A common connexion between gap junctions, single nucleotide polymorphisms, and atrial fibrillation? Can J Cardiol. 2013 Jan; 29(1):3-5.
    View in: PubMed
    Score: 0.533
  6. Independent susceptibility markers for atrial fibrillation on chromosome 4q25. Circulation. 2010 Sep 07; 122(10):976-84.
    View in: PubMed
    Score: 0.458
  7. Challenges in the classification of atrial fibrillation. Nat Rev Cardiol. 2010 Aug; 7(8):451-60.
    View in: PubMed
    Score: 0.453
  8. Genetics of atrial fibrillation: implications for future research directions and personalized medicine. Circ Arrhythm Electrophysiol. 2010 Jun; 3(3):291-9.
    View in: PubMed
    Score: 0.451
  9. Effectiveness of cardiac resynchronization therapy in mild congestive heart failure: systematic review and meta-analysis of randomized trials. Eur J Heart Fail. 2010 Apr; 12(4):360-6.
    View in: PubMed
    Score: 0.446
  10. Atrial fibrillation in congestive heart failure. Heart Fail Clin. 2010 Apr; 6(2):187-200.
    View in: PubMed
    Score: 0.446
  11. Genetics of atrial fibrillation. Heart Fail Clin. 2010 Apr; 6(2):239-47.
    View in: PubMed
    Score: 0.446
  12. Genetics of atrial fibrillation. Cardiol Clin. 2009 Feb; 27(1):25-33, vii.
    View in: PubMed
    Score: 0.411
  13. Comparative Clinical Effectiveness of Population-Based Atrial Fibrillation Screening Using Contemporary Modalities: A Decision-Analytic Model. J Am Heart Assoc. 2021 09 21; 10(18):e020330.
    View in: PubMed
    Score: 0.246
  14. Predictive Accuracy of a Clinical and Genetic Risk Model for Atrial Fibrillation. Circ Genom Precis Med. 2021 10; 14(5):e003355.
    View in: PubMed
    Score: 0.246
  15. Accelerometer-derived physical activity and risk of atrial fibrillation. Eur Heart J. 2021 07 01; 42(25):2472-2483.
    View in: PubMed
    Score: 0.243
  16. Deep Learning to Predict Cardiac Magnetic Resonance-Derived Left Ventricular Mass and Hypertrophy From 12-Lead ECGs. Circ Cardiovasc Imaging. 2021 06; 14(6):e012281.
    View in: PubMed
    Score: 0.242
  17. Usefulness of Rhythm Monitoring Following Acute Ischemic Stroke. Am J Cardiol. 2021 05 15; 147:44-51.
    View in: PubMed
    Score: 0.237
  18. Non-Vitamin K Antagonist Oral Anticoagulant vs Warfarin for Post Cardiac Surgery Atrial Fibrillation. Ann Thorac Surg. 2021 11; 112(5):1392-1401.
    View in: PubMed
    Score: 0.235
  19. Performance of Atrial Fibrillation Risk Prediction Models in Over 4 Million Individuals. Circ Arrhythm Electrophysiol. 2021 01; 14(1):e008997.
    View in: PubMed
    Score: 0.234
  20. Epigenetic Analyses of Human Left Atrial Tissue Identifies Gene Networks Underlying Atrial Fibrillation. Circ Genom Precis Med. 2020 12; 13(6):e003085.
    View in: PubMed
    Score: 0.232
  21. Associations Between Alcohol Intake and Genetic Predisposition With Atrial Fibrillation Risk in a National Biobank. Circ Genom Precis Med. 2020 12; 13(6):e003111.
    View in: PubMed
    Score: 0.232
  22. Genetic Determinants of Electrocardiographic P-Wave Duration and Relation to Atrial Fibrillation. Circ Genom Precis Med. 2020 10; 13(5):387-395.
    View in: PubMed
    Score: 0.229
  23. Atrial Fibrillation Risk and Discrimination of Cardioembolic From Noncardioembolic Stroke. Stroke. 2020 05; 51(5):1396-1403.
    View in: PubMed
    Score: 0.223
  24. Genetic Susceptibility for Atrial Fibrillation in Patients Undergoing Atrial Fibrillation Ablation. Circ Arrhythm Electrophysiol. 2020 03; 13(3):e007676.
    View in: PubMed
    Score: 0.221
  25. Initial Precipitants and Recurrence of Atrial Fibrillation. Circ Arrhythm Electrophysiol. 2020 03; 13(3):e007716.
    View in: PubMed
    Score: 0.221
  26. Monogenic and Polygenic Contributions to Atrial Fibrillation Risk: Results From a National Biobank. Circ Res. 2020 01 17; 126(2):200-209.
    View in: PubMed
    Score: 0.217
  27. Development and Validation of a Prediction Model for Atrial Fibrillation Using Electronic Health Records. JACC Clin Electrophysiol. 2019 11; 5(11):1331-1341.
    View in: PubMed
    Score: 0.215
  28. Response by Aragam et al to Letter Regarding Article, "Phenotypic Refinement of Heart Failure in a National Biobank Facilitates Genetic Discovery". Circulation. 2019 07 02; 140(1):e7-e8.
    View in: PubMed
    Score: 0.212
  29. Design and rationale of a pragmatic trial integrating routine screening for atrial fibrillation at primary care visits: The VITAL-AF trial. Am Heart J. 2019 09; 215:147-156.
    View in: PubMed
    Score: 0.211
  30. Electronic physician notifications to improve guideline-based anticoagulation in atrial fibrillation: a randomized controlled trial. J Gen Intern Med. 2018 12; 33(12):2070-2077.
    View in: PubMed
    Score: 0.199
  31. Frequency of Cardiac Rhythm Abnormalities in a Half Million Adults. Circ Arrhythm Electrophysiol. 2018 07; 11(7):e006273.
    View in: PubMed
    Score: 0.197
  32. Multi-ethnic genome-wide association study for atrial fibrillation. Nat Genet. 2018 06 11; 50(9):1225-1233.
    View in: PubMed
    Score: 0.197
  33. Common Coding Variants in SCN10A Are Associated With the Nav1.8 Late Current and Cardiac Conduction. Circ Genom Precis Med. 2018 05; 11(5):e001663.
    View in: PubMed
    Score: 0.195
  34. Novel Mutation in FLNC (Filamin C) Causes Familial Restrictive Cardiomyopathy. Circ Cardiovasc Genet. 2017 Dec; 10(6).
    View in: PubMed
    Score: 0.190
  35. Heritability of Atrial Fibrillation. Circ Cardiovasc Genet. 2017 Dec; 10(6).
    View in: PubMed
    Score: 0.190
  36. Genetic Predisposition, Clinical Risk Factor Burden, and Lifetime Risk of Atrial Fibrillation. Circulation. 2018 03 06; 137(10):1027-1038.
    View in: PubMed
    Score: 0.189
  37. Diminished PRRX1 Expression Is Associated With Increased Risk of Atrial Fibrillation and Shortening of the Cardiac Action Potential. Circ Cardiovasc Genet. 2017 Oct; 10(5).
    View in: PubMed
    Score: 0.187
  38. Genetic Interactions with Age, Sex, Body Mass Index, and Hypertension in Relation to Atrial Fibrillation: The AFGen Consortium. Sci Rep. 2017 09 12; 7(1):11303.
    View in: PubMed
    Score: 0.187
  39. Genomic basis of atrial fibrillation. Heart. 2018 02; 104(3):201-206.
    View in: PubMed
    Score: 0.187
  40. Fifteen Genetic Loci Associated With the Electrocardiographic P Wave. Circ Cardiovasc Genet. 2017 Aug; 10(4).
    View in: PubMed
    Score: 0.185
  41. Factors Associated with Anticoagulation Delay Following New-Onset Atrial Fibrillation. Am J Cardiol. 2017 Oct 15; 120(8):1316-1321.
    View in: PubMed
    Score: 0.185
  42. Genetics of Atrial Fibrillation: State of the Art in 2017. Heart Lung Circ. 2017 Sep; 26(9):894-901.
    View in: PubMed
    Score: 0.182
  43. Atrial Fibrillation Genetic Risk and Ischemic Stroke Mechanisms. Stroke. 2017 06; 48(6):1451-1456.
    View in: PubMed
    Score: 0.182
  44. Stroke as the Initial Manifestation of Atrial Fibrillation: The Framingham Heart Study. Stroke. 2017 02; 48(2):490-492.
    View in: PubMed
    Score: 0.178
  45. A Functional Variant Associated with Atrial Fibrillation Regulates PITX2c Expression through TFAP2a. Am J Hum Genet. 2016 Dec 01; 99(6):1281-1291.
    View in: PubMed
    Score: 0.177
  46. Gene-gene Interaction Analyses for Atrial Fibrillation. Sci Rep. 2016 11 08; 6:35371.
    View in: PubMed
    Score: 0.176
  47. Genetic Risk Prediction of Atrial Fibrillation. Circulation. 2017 Apr 04; 135(14):1311-1320.
    View in: PubMed
    Score: 0.176
  48. Whole Exome Sequencing in Atrial Fibrillation. PLoS Genet. 2016 09; 12(9):e1006284.
    View in: PubMed
    Score: 0.174
  49. Atrial Fibrillation Genetics: Is There a Practical Clinical Value Now or in the Future? Can J Cardiol. 2016 11; 32(11):1300-1305.
    View in: PubMed
    Score: 0.167
  50. Programmed Ventricular Stimulation for Risk Stratification in the Brugada Syndrome: A Pooled Analysis. Circulation. 2016 Feb 16; 133(7):622-30.
    View in: PubMed
    Score: 0.167
  51. A Simple and Portable Algorithm for Identifying Atrial Fibrillation in the Electronic Medical Record. Am J Cardiol. 2016 Jan 15; 117(2):221-5.
    View in: PubMed
    Score: 0.164
  52. Long-term outcomes of secondary atrial fibrillation in the community: the Framingham Heart Study. Circulation. 2015 May 12; 131(19):1648-55.
    View in: PubMed
    Score: 0.157
  53. Integrating genetic, transcriptional, and functional analyses to identify 5 novel genes for atrial fibrillation. Circulation. 2014 Oct 07; 130(15):1225-35.
    View in: PubMed
    Score: 0.151
  54. Atrial fibrillation patterns and risks of subsequent stroke, heart failure, or death in the community. J Am Heart Assoc. 2013 Sep 03; 2(5):e000126.
    View in: PubMed
    Score: 0.141
  55. Genetic etiology and evaluation of sudden cardiac death. Curr Cardiol Rep. 2013 Aug; 15(8):389.
    View in: PubMed
    Score: 0.140
  56. Meta-analysis identifies six new susceptibility loci for atrial fibrillation. Nat Genet. 2012 Apr 29; 44(6):670-5.
    View in: PubMed
    Score: 0.129
  57. Genetic variation in the alternative splicing regulator RBM20 is associated with dilated cardiomyopathy. Heart Rhythm. 2012 Mar; 9(3):390-6.
    View in: PubMed
    Score: 0.124
  58. Elevation of parathyroid hormone levels in atrial fibrillation. J Am Coll Cardiol. 2011 Jun 21; 57(25):2542-3.
    View in: PubMed
    Score: 0.121
  59. Atrial fibrillation and death after myocardial infarction: risk marker or causal mediator? Circulation. 2011 May 17; 123(19):2063-5.
    View in: PubMed
    Score: 0.120
  60. Monogenic atrial fibrillation as pathophysiological paradigms. Cardiovasc Res. 2011 Mar 01; 89(4):692-700.
    View in: PubMed
    Score: 0.117
  61. Association between familial atrial fibrillation and risk of new-onset atrial fibrillation. JAMA. 2010 Nov 24; 304(20):2263-9.
    View in: PubMed
    Score: 0.116
  62. Genome-wide association studies in cardiac electrophysiology: recent discoveries and implications for clinical practice. Heart Rhythm. 2010 Aug; 7(8):1141-8.
    View in: PubMed
    Score: 0.112
  63. Stroke risk in AF: do AF patterns matter? Eur Heart J. 2010 Apr; 31(8):908-10.
    View in: PubMed
    Score: 0.111
  64. Common variants in KCNN3 are associated with lone atrial fibrillation. Nat Genet. 2010 Mar; 42(3):240-4.
    View in: PubMed
    Score: 0.111
  65. Re-CHARGE-AF: Recalibration of the CHARGE-AF Model for Atrial Fibrillation Risk Prediction in Patients With Acute Stroke. J Am Heart Assoc. 2021 Nov 02; 10(21):e022363.
    View in: PubMed
    Score: 0.062
  66. Epigenetic Age and the Risk of Incident Atrial Fibrillation. Circulation. 2021 Sep 30.
    View in: PubMed
    Score: 0.062
  67. Early-Onset Atrial Fibrillation and the Prevalence of Rare Variants in Cardiomyopathy and Arrhythmia Genes. JAMA Cardiol. 2021 Sep 08.
    View in: PubMed
    Score: 0.062
  68. The genomics of heart failure: design and rationale of the HERMES consortium. ESC Heart Fail. 2021 Sep 03.
    View in: PubMed
    Score: 0.062
  69. Rare Coding Variants Associated With Electrocardiographic Intervals Identify Monogenic Arrhythmia Susceptibility Genes: A Multi-Ancestry Analysis. Circ Genom Precis Med. 2021 08; 14(4):e003300.
    View in: PubMed
    Score: 0.061
  70. Robust, flexible, and scalable tests for Hardy-Weinberg equilibrium across diverse ancestries. Genetics. 2021 05 17; 218(1).
    View in: PubMed
    Score: 0.060
  71. Chromosome Xq23 is associated with lower atherogenic lipid concentrations and favorable cardiometabolic indices. Nat Commun. 2021 04 12; 12(1):2182.
    View in: PubMed
    Score: 0.060
  72. Author Correction: Inherited causes of clonal haematopoiesis in 97,691 whole genomes. Nature. 2021 Mar; 591(7851):E27.
    View in: PubMed
    Score: 0.059
  73. Sequencing of 53,831 diverse genomes from the NHLBI TOPMed Program. Nature. 2021 02; 590(7845):290-299.
    View in: PubMed
    Score: 0.059
  74. Genetic Risk Score to Identify Risk of Venous Thromboembolism in Patients With Cardiometabolic Disease. Circ Genom Precis Med. 2021 02; 14(1):e003006.
    View in: PubMed
    Score: 0.059
  75. Loss-of-function genomic variants highlight potential therapeutic targets for cardiovascular disease. Nat Commun. 2020 12 18; 11(1):6417.
    View in: PubMed
    Score: 0.059
  76. Clinical Application of a Novel Genetic Risk Score for Ischemic Stroke in Patients With Cardiometabolic Disease. Circulation. 2021 Feb 02; 143(5):470-478.
    View in: PubMed
    Score: 0.058
  77. Inherited causes of clonal haematopoiesis in 97,691 whole genomes. Nature. 2020 10; 586(7831):763-768.
    View in: PubMed
    Score: 0.058
  78. Enhancing rare variant interpretation in inherited arrhythmias through quantitative analysis of consortium disease cohorts and population controls. Genet Med. 2021 01; 23(1):47-58.
    View in: PubMed
    Score: 0.057
  79. Limitations of Contemporary Guidelines for Managing Patients at High Genetic Risk of Coronary Artery Disease. J Am Coll Cardiol. 2020 06 09; 75(22):2769-2780.
    View in: PubMed
    Score: 0.056
  80. Multi-ancestry GWAS of the electrocardiographic PR interval identifies 202 loci underlying cardiac conduction. Nat Commun. 2020 05 21; 11(1):2542.
    View in: PubMed
    Score: 0.056
  81. Transethnic Genome-Wide Association Study Provides Insights in the Genetic Architecture and Heritability of Long QT Syndrome. Circulation. 2020 07 28; 142(4):324-338.
    View in: PubMed
    Score: 0.056
  82. Analysis of cardiac magnetic resonance imaging in 36,000 individuals yields genetic insights into dilated cardiomyopathy. Nat Commun. 2020 05 07; 11(1):2254.
    View in: PubMed
    Score: 0.056
  83. Genetically Determined Birthweight Associates With Atrial Fibrillation: A Mendelian Randomization Study. Circ Genom Precis Med. 2020 06; 13(3):e002553.
    View in: PubMed
    Score: 0.056
  84. Novel Risk Modeling Approach of Atrial Fibrillation With Restricted Mean Survival Times: Application in the Framingham Heart Study Community-Based Cohort. Circ Cardiovasc Qual Outcomes. 2020 04; 13(4):e005918.
    View in: PubMed
    Score: 0.056
  85. The Effect of PCSK9 (Proprotein Convertase Subtilisin/Kexin Type 9) Inhibition on the Risk of Venous Thromboembolism. Circulation. 2020 05 19; 141(20):1600-1607.
    View in: PubMed
    Score: 0.056
  86. Titin Truncating Variants in Adults Without Known Congestive Heart Failure. J Am Coll Cardiol. 2020 03 17; 75(10):1239-1241.
    View in: PubMed
    Score: 0.056
  87. Protein Biomarkers and Risk of Atrial Fibrillation: The FHS. Circ Arrhythm Electrophysiol. 2020 02; 13(2):e007607.
    View in: PubMed
    Score: 0.055
  88. Genome-wide association and Mendelian randomisation analysis provide insights into the pathogenesis of heart failure. Nat Commun. 2020 01 09; 11(1):163.
    View in: PubMed
    Score: 0.055
  89. Use of >100,000 NHLBI Trans-Omics for Precision Medicine (TOPMed) Consortium whole genome sequences improves imputation quality and detection of rare variant associations in admixed African and Hispanic/Latino populations. PLoS Genet. 2019 12; 15(12):e1008500.
    View in: PubMed
    Score: 0.055
  90. Integrative Omics Approach to Identifying Genes Associated With Atrial Fibrillation. Circ Res. 2020 01 31; 126(3):350-360.
    View in: PubMed
    Score: 0.055
  91. Predicting Benefit From Evolocumab Therapy in Patients With Atherosclerotic Disease Using a Genetic Risk Score: Results From the FOURIER Trial. Circulation. 2020 02 25; 141(8):616-623.
    View in: PubMed
    Score: 0.054
  92. Refining the Association Between Body Mass Index and Atrial Fibrillation: G-Formula and Restricted Mean Survival Times. J Am Heart Assoc. 2019 08 20; 8(16):e013011.
    View in: PubMed
    Score: 0.053
  93. Publisher Correction: Protein-altering variants associated with body mass index implicate pathways that control energy intake and expenditure in obesity. Nat Genet. 2019 Jul; 51(7):1191-1192.
    View in: PubMed
    Score: 0.053
  94. Publisher Correction: Multiancestry genome-wide association study of 520,000 subjects identifies 32 loci associated with stroke and stroke subtypes. Nat Genet. 2019 Jul; 51(7):1192-1193.
    View in: PubMed
    Score: 0.053
  95. Genetic Link Between Arterial Stiffness and Atrial Fibrillation. Circ Genom Precis Med. 2019 06; 12(6):e002453.
    View in: PubMed
    Score: 0.053
  96. Proteomics Profiling and Risk of New-Onset Atrial Fibrillation: Framingham Heart Study. J Am Heart Assoc. 2019 03 19; 8(6):e010976.
    View in: PubMed
    Score: 0.052
  97. Assessment of the Relationship Between Genetic Determinants of Thyroid Function and Atrial Fibrillation: A Mendelian Randomization Study. JAMA Cardiol. 2019 02 01; 4(2):144-152.
    View in: PubMed
    Score: 0.051
  98. A Genetic Risk Score for Atrial Fibrillation Predicts the Response to Catheter Ablation. Korean Circ J. 2019 Apr; 49(4):338-349.
    View in: PubMed
    Score: 0.051
  99. Association Between Titin Loss-of-Function Variants and Early-Onset Atrial Fibrillation. JAMA. 2018 12 11; 320(22):2354-2364.
    View in: PubMed
    Score: 0.051
  100. Atrial fibrillation genetic risk differentiates cardioembolic stroke from other stroke subtypes. Neurol Genet. 2018 Dec; 4(6):e293.
    View in: PubMed
    Score: 0.051
  101. Phenotypic Refinement of Heart Failure in a National Biobank Facilitates Genetic Discovery. Circulation. 2018 Nov 11.
    View in: PubMed
    Score: 0.051
  102. Genome-wide polygenic scores for common diseases identify individuals with risk equivalent to monogenic mutations. Nat Genet. 2018 09; 50(9):1219-1224.
    View in: PubMed
    Score: 0.050
  103. PR interval genome-wide association meta-analysis identifies 50 loci associated with atrial and atrioventricular electrical activity. Nat Commun. 2018 07 25; 9(1):2904.
    View in: PubMed
    Score: 0.050
  104. Exome-chip meta-analysis identifies novel loci associated with cardiac conduction, including ADAMTS6. Genome Biol. 2018 07 17; 19(1):87.
    View in: PubMed
    Score: 0.050
  105. Common and Rare Coding Genetic Variation Underlying the Electrocardiographic PR Interval. Circ Genom Precis Med. 2018 05; 11(5):e002037.
    View in: PubMed
    Score: 0.049
  106. Publisher Correction: Protein-altering variants associated with body mass index implicate pathways that control energy intake and expenditure in obesity. Nat Genet. 2018 05; 50(5):765-766.
    View in: PubMed
    Score: 0.049
  107. Publisher Correction: Protein-altering variants associated with body mass index implicate pathways that control energy intake and expenditure in obesity. Nat Genet. 2018 05; 50(5):766-767.
    View in: PubMed
    Score: 0.049
  108. Lifetime risk of atrial fibrillation according to optimal, borderline, or elevated levels of risk factors: cohort study based on longitudinal data from the Framingham Heart Study. BMJ. 2018 04 26; 361:k1453.
    View in: PubMed
    Score: 0.049
  109. Multiancestry genome-wide association study of 520,000 subjects identifies 32 loci associated with stroke and stroke subtypes. Nat Genet. 2018 04; 50(4):524-537.
    View in: PubMed
    Score: 0.048
  110. ExomeChip-Wide Analysis of 95 626 Individuals Identifies 10 Novel Loci Associated With QT and JT Intervals. Circ Genom Precis Med. 2018 01; 11(1):e001758.
    View in: PubMed
    Score: 0.048
  111. Protein-altering variants associated with body mass index implicate pathways that control energy intake and expenditure in obesity. Nat Genet. 2018 01; 50(1):26-41.
    View in: PubMed
    Score: 0.048
  112. Association Between Leukocyte Telomere Length and the Risk of Incident Atrial Fibrillation: The Framingham Heart Study. J Am Heart Assoc. 2017 Nov 14; 6(11).
    View in: PubMed
    Score: 0.047
  113. Validation of Polygenic Scores for QT Interval in Clinical Populations. Circ Cardiovasc Genet. 2017 Oct; 10(5).
    View in: PubMed
    Score: 0.047
  114. Erratum: Genetic loci associated with heart rate variability and their effects on cardiac disease risk. Nat Commun. 2017 08 02; 8:16140.
    View in: PubMed
    Score: 0.046
  115. Erratum: Large-scale analyses of common and rare variants identify 12 new loci associated with atrial fibrillation. Nat Genet. 2017 07 27; 49(8):1286.
    View in: PubMed
    Score: 0.046
  116. Discovery of novel heart rate-associated loci using the Exome Chip. Hum Mol Genet. 2017 06 15; 26(12):2346-2363.
    View in: PubMed
    Score: 0.046
  117. Genetic loci associated with heart rate variability and their effects on cardiac disease risk. Nat Commun. 2017 06 14; 8:15805.
    View in: PubMed
    Score: 0.046
  118. Relations of Liver Fat With Prevalent and Incident Atrial Fibrillation in the Framingham Heart Study. J Am Heart Assoc. 2017 May 02; 6(5).
    View in: PubMed
    Score: 0.046
  119. Large-scale analyses of common and rare variants identify 12 new loci associated with atrial fibrillation. Nat Genet. 2017 Jun; 49(6):946-952.
    View in: PubMed
    Score: 0.045
  120. Rare and low-frequency coding variants alter human adult height. Nature. 2017 02 09; 542(7640):186-190.
    View in: PubMed
    Score: 0.045
  121. Methylome-wide Association Study of Atrial Fibrillation in Framingham Heart Study. Sci Rep. 2017 01 09; 7:40377.
    View in: PubMed
    Score: 0.045
  122. Genetic Obesity and the Risk of Atrial Fibrillation: Causal Estimates from Mendelian Randomization. Circulation. 2017 Feb 21; 135(8):741-754.
    View in: PubMed
    Score: 0.044
  123. Serum brain-derived neurotrophic factor and risk of atrial fibrillation. Am Heart J. 2017 Jan; 183:69-73.
    View in: PubMed
    Score: 0.044
  124. Metabolomic Profiling in Relation to New-Onset Atrial Fibrillation (from the Framingham Heart Study). Am J Cardiol. 2016 11 15; 118(10):1493-1496.
    View in: PubMed
    Score: 0.043
  125. Relations of Arterial Stiffness and Brachial Flow-Mediated Dilation With New-Onset Atrial Fibrillation: The Framingham Heart Study. Hypertension. 2016 09; 68(3):590-6.
    View in: PubMed
    Score: 0.043
  126. Trajectories of Risk Factors and Risk of New-Onset Atrial Fibrillation in the Framingham Heart Study. Hypertension. 2016 09; 68(3):597-605.
    View in: PubMed
    Score: 0.043
  127. Response to Letter Regarding Article, "Atrial Fibrillation Begets Heart Failure and Vice Versa: Temporal Associations and Differences in Preserved Versus Reduced Ejection Fraction". Circulation. 2016 Jun 07; 133(23):e692-3.
    View in: PubMed
    Score: 0.043
  128. A comparison of the CHARGE-AF and the CHA2DS2-VASc risk scores for prediction of atrial fibrillation in the Framingham Heart Study. Am Heart J. 2016 Aug; 178:45-54.
    View in: PubMed
    Score: 0.043
  129. Atrial fibrillation without comorbidities: Prevalence, incidence and prognosis (from the Framingham Heart Study). Am Heart J. 2016 07; 177:138-44.
    View in: PubMed
    Score: 0.042
  130. Effect of a Multidisciplinary Approach for the Management of Patients With Atrial Fibrillation in the Emergency Department on Hospital Admission Rate and Length of Stay. Am J Cardiol. 2016 Jul 01; 118(1):64-71.
    View in: PubMed
    Score: 0.042
  131. Asymmetric dimethylarginine, related arginine derivatives, and incident atrial fibrillation. Am Heart J. 2016 06; 176:100-6.
    View in: PubMed
    Score: 0.042
  132. Electrocardiographic Early Repolarization: A Scientific Statement From the American Heart Association. Circulation. 2016 Apr 12; 133(15):1520-9.
    View in: PubMed
    Score: 0.042
  133. Atrial Fibrillation Begets Heart Failure and Vice Versa: Temporal Associations and Differences in Preserved Versus Reduced Ejection Fraction. Circulation. 2016 Feb 02; 133(5):484-92.
    View in: PubMed
    Score: 0.042
  134. Korean Atrial Fibrillation (AF) Network: Genetic Variants for AF Do Not Predict Ablation Success. J Am Heart Assoc. 2015 Aug 13; 4(8):e002046.
    View in: PubMed
    Score: 0.040
  135. Atrial flutter: Clinical risk factors and adverse outcomes in the Framingham Heart Study. Heart Rhythm. 2016 Jan; 13(1):233-40.
    View in: PubMed
    Score: 0.040
  136. 50 year trends in atrial fibrillation prevalence, incidence, risk factors, and mortality in the Framingham Heart Study: a cohort study. Lancet. 2015 Jul 11; 386(9989):154-62.
    View in: PubMed
    Score: 0.040
  137. Common genetic variants and response to atrial fibrillation ablation. Circ Arrhythm Electrophysiol. 2015 Apr; 8(2):296-302.
    View in: PubMed
    Score: 0.039
  138. Blood lipids and the incidence of atrial fibrillation: the Multi-Ethnic Study of Atherosclerosis and the Framingham Heart Study. J Am Heart Assoc. 2014 Oct 07; 3(5):e001211.
    View in: PubMed
    Score: 0.038
  139. Twelve-single nucleotide polymorphism genetic risk score identifies individuals at increased risk for future atrial fibrillation and stroke. Stroke. 2014 Oct; 45(10):2856-2862.
    View in: PubMed
    Score: 0.038
  140. B-type natriuretic peptide and C-reactive protein in the prediction of atrial fibrillation risk: the CHARGE-AF Consortium of community-based cohort studies. Europace. 2014 Oct; 16(10):1426-33.
    View in: PubMed
    Score: 0.038
  141. Sequencing of SCN5A identifies rare and common variants associated with cardiac conduction: Cohorts for Heart and Aging Research in Genomic Epidemiology (CHARGE) Consortium. Circ Cardiovasc Genet. 2014 Jun; 7(3):365-73.
    View in: PubMed
    Score: 0.037
  142. Whole blood gene expression and atrial fibrillation: the Framingham Heart Study. PLoS One. 2014; 9(5):e96794.
    View in: PubMed
    Score: 0.037
  143. Genetic loci associated with atrial fibrillation: relation to left atrial structure in the Framingham Heart Study. J Am Heart Assoc. 2014 Apr 02; 3(2):e000616.
    View in: PubMed
    Score: 0.037
  144. Galectin 3 and incident atrial fibrillation in the community. Am Heart J. 2014 May; 167(5):729-34.e1.
    View in: PubMed
    Score: 0.037
  145. Targeted sequencing in candidate genes for atrial fibrillation: the Cohorts for Heart and Aging Research in Genomic Epidemiology (CHARGE) Targeted Sequencing Study. Heart Rhythm. 2014 Mar; 11(3):452-7.
    View in: PubMed
    Score: 0.036
  146. Reciprocal relations between physical disability, subjective health, and atrial fibrillation: the Framingham Heart Study. Am Heart J. 2013 Jul; 166(1):171-8.
    View in: PubMed
    Score: 0.035
  147. Risk assessment for incident heart failure in individuals with atrial fibrillation. Eur J Heart Fail. 2013 Aug; 15(8):843-9.
    View in: PubMed
    Score: 0.034
  148. Simple risk model predicts incidence of atrial fibrillation in a racially and geographically diverse population: the CHARGE-AF consortium. J Am Heart Assoc. 2013 Mar 18; 2(2):e000102.
    View in: PubMed
    Score: 0.034
  149. Common genetic variation near the connexin-43 gene is associated with resting heart rate in African Americans: a genome-wide association study of 13,372 participants. Heart Rhythm. 2013 Mar; 10(3):401-8.
    View in: PubMed
    Score: 0.033
  150. Low serum magnesium and the development of atrial fibrillation in the community: the Framingham Heart Study. Circulation. 2013 Jan 01; 127(1):33-8.
    View in: PubMed
    Score: 0.033
  151. Novel loci associated with PR interval in a genome-wide association study of 10 African American cohorts. Circ Cardiovasc Genet. 2012 Dec; 5(6):639-46.
    View in: PubMed
    Score: 0.033
  152. Symptoms and functional status of patients with atrial fibrillation: state of the art and future research opportunities. Circulation. 2012 Jun 12; 125(23):2933-43.
    View in: PubMed
    Score: 0.032
  153. Age of natural menopause and atrial fibrillation: the Framingham Heart Study. Am Heart J. 2012 Apr; 163(4):729-34.
    View in: PubMed
    Score: 0.032
  154. White blood cell count and risk of incident atrial fibrillation (from the Framingham Heart Study). Am J Cardiol. 2012 Feb 15; 109(4):533-7.
    View in: PubMed
    Score: 0.031
  155. Plasma resistin, adiponectin, and risk of incident atrial fibrillation: the Framingham Offspring Study. Am Heart J. 2012 Jan; 163(1):119-124.e1.
    View in: PubMed
    Score: 0.031
  156. Atrial fibrillation: current knowledge and future directions in epidemiology and genomics. Circulation. 2011 Nov 01; 124(18):1982-93.
    View in: PubMed
    Score: 0.031
  157. Insulin resistance and atrial fibrillation (from the Framingham Heart Study). Am J Cardiol. 2012 Jan 01; 109(1):87-90.
    View in: PubMed
    Score: 0.031
  158. Large-scale candidate gene analysis in whites and African Americans identifies IL6R polymorphism in relation to atrial fibrillation: the National Heart, Lung, and Blood Institute's Candidate Gene Association Resource (CARe) project. Circ Cardiovasc Genet. 2011 Oct; 4(5):557-64.
    View in: PubMed
    Score: 0.031
  159. Vitamin D status is not related to development of atrial fibrillation in the community. Am Heart J. 2011 Sep; 162(3):538-41.
    View in: PubMed
    Score: 0.031
  160. Genome-wide association studies of the PR interval in African Americans. PLoS Genet. 2011 Feb 10; 7(2):e1001304.
    View in: PubMed
    Score: 0.030
  161. P wave duration and risk of longitudinal atrial fibrillation in persons = 60 years old (from the Framingham Heart Study). Am J Cardiol. 2011 Mar 15; 107(6):917-921.e1.
    View in: PubMed
    Score: 0.029
  162. European ancestry as a risk factor for atrial fibrillation in African Americans. Circulation. 2010 Nov 16; 122(20):2009-15.
    View in: PubMed
    Score: 0.029
  163. A common connexin-40 gene promoter variant affects connexin-40 expression in human atria and is associated with atrial fibrillation. Circ Arrhythm Electrophysiol. 2011 Feb; 4(1):87-93.
    View in: PubMed
    Score: 0.029
  164. Lack of replication in polymorphisms reported to be associated with atrial fibrillation. Heart Rhythm. 2011 Mar; 8(3):403-9.
    View in: PubMed
    Score: 0.029
  165. P-wave indices: derivation of reference values from the Framingham Heart Study. Ann Noninvasive Electrocardiol. 2010 Oct; 15(4):344-52.
    View in: PubMed
    Score: 0.029
  166. Evaluation of non-synonymous NPPA single nucleotide polymorphisms in atrial fibrillation. Europace. 2010 Aug; 12(8):1078-83.
    View in: PubMed
    Score: 0.028
  167. Genome-wide association study of PR interval. Nat Genet. 2010 Feb; 42(2):153-9.
    View in: PubMed
    Score: 0.027
  168. Variants in ZFHX3 are associated with atrial fibrillation in individuals of European ancestry. Nat Genet. 2009 Aug; 41(8):879-81.
    View in: PubMed
    Score: 0.027
Connection Strength
The connection strength for co-authors is the sum of the scores for each of their shared publications.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.